300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Travel
Local
Enterprise Software
InsurTech
Oil and Gas
Platforms
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Canada
Slovenia
San Marino
Ukraine
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Merantix Capital, VC Fund

Merantix Capital

VC Fund

Berlin, Germany

Merantix Capital is a VC fund in Berlin focused on Artificial Intelligence and Machine Learning. At Merantix Venture Studio we ideate, build and scale AI companies. Through our unique incubation platform, seed financing and exceptional teams of entrepreneurs and engineers, we transfer world-leading research into ventures that will disrupt existing and create new industries.

Total investments:
31
Last investment:
Lead investor:
58%

Last updated:

Industries Merantix Capital invests in

Artificial IntelligenceMachine LearningSoftwareAnalyticsHealth Care

Stages Merantix Capital invests in

Pre-SeedSeedSeries AFunding Round

Countries Merantix Capital invests in

GermanySwitzerlandUnited Kingdom

Round sizes

Seed $4.3M–$6.6MPre-Seed $1.1M–$3.5MSeries A $4.5M–$19M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

1 more contact available

Round size

Seed
$4.3M–$6.6M
Pre-Seed
$1.1M–$3.5M
Series A
$4.5M–$19M

Investment Focus

Industry

  • Artificial Intelligence 9 (29%)
  • Machine Learning 6 (19%)
  • Software 3 (10%)
  • Analytics 3 (10%)
  • Health Care 3 (10%)
See all 36 industries →

Stage

  • Pre-Seed 12 (39%)
  • Seed 10 (32%)
  • Series A 2 (6%)
  • Funding Round 1 (3%)

Country

  • Germany 14 (45%)
  • Switzerland 1 (3%)
  • United Kingdom 1 (3%)

Team

NameTitleInvestmentsLinksEmail
Adrian Locher
Adrian Locher Founder, CEO and General Partner
Founder, CEO and General Partner Total investments: 10
Find email
Janette Wiget
Janette Wiget Chief Financial Officer
Chief Financial Officer Total investments: 1
Find email
Rasmus Rothe
Rasmus Rothe Founder
Founder Total investments: 4
Find email
Sona Chandra
Sona Chandra Founder
Founder Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Almetra Almetra
AI-based process analytics platform to increase productivity and quality in manual processes. Processes are captured using computer vision and automatically analysed with a highly flexible AI to identify improvement potential.1. Real-time capture with cameras Cameras are installed at individual assembly stations capturing live video streams ofassembly or packaging tasks.2. AI tracks material & work steps Video streams are continuously analyzed to detect workpiece movements, cycle times, and work step sequencing.3. Aggregation for data analysis Process data is aggregated per article and production to provide insights on process performance. Video snippets allow for a comprehensive root-cause analysis.4. Data-driven improvements Your factory managers and process engineers define, implement and measure process improvements to increase productivity and quality in your assembly line. $18.5M / Series A / Jun 25, 2026
Graph Therapeutics Graph Therapeutics
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. $5M / Seed / Jun 22, 2026
WhyBrilliant WhyBrilliant
WhyBrilliant operates as a B2B platform marketplace that utilizes conversational voice artificial intelligence to automate job matching. The company's core business model reverses the traditional hiring framework by having pre-vetted corporate clients submit inquiries to anonymized, AI-screened talent. Its consumer value proposition centers oneliminating standard application forms and manual recruiter screenings by deploying an AI assistant to privately map candidate objectives and facilitate secure introductions. This structural approach enables employers to optimize their hiring pipeline efficiency while guaranteeing job seekers profile confidentiality from current employers. $1.2M / Pre-Seed / Jun 16, 2026
OutPost Bio OutPost Bio
OutPost Bio aims to unlock new ways to design drugs, ingredients, and consumer health products by boosting its experimental and modelling platforms. $3.5M / Pre-Seed / Mar 02, 2026
FICUS HEALTH FICUS HEALTH
FICUS HEALTH is a Berlin-based company that automates documentation using AI-based software. Seed / Dec 11, 2025
Arqh Arqh
Arqh is a decision intelligence engine that converts your business objectives into real-time operational decisions. $3.8M / Pre-Seed / Sep 30, 2025
revel8 revel8
revel8 (formerly Company Shield) helps organizations stop GenAI-powered social engineering attacks with real-time, personalized simulations across email, SMS, chat, voice, and video. The AI-driven platform mirrors real attack tactics, adapts to each user’s risk profile, and reinforces awareness through gamified, habit-forming training. $6.6M / Seed / Sep 25, 2025
Droidrun Droidrun
Droidrun is a cutting-edge software development company that specializes in creating innovative solutions enabling AI agents to seamlessly access and control smartphone applications. By leveraging advanced artificial intelligence and machine learning algorithms, their software facilitates smooth interactions between AI systems and mobile devices,empowering agents to autonomously navigate, operate, and optimize a wide range of apps on both Android and iOS platforms. $2.5M / Pre-Seed / Jul 23, 2025
Graph Therapeutics Graph Therapeutics
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. $3.1M / Pre-Seed / Jan 09, 2025
Briink Briink
Briink leverages AI to automate the workflows of sustainable finance teams $4.3M / Seed / Sep 30, 2024
See all 31 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Travel
Local
Enterprise Software
InsurTech
Oil and Gas
Platforms
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Canada
Slovenia
San Marino
Ukraine
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Merantix Capital invest in?

Merantix Capital invests primarily in Artificial Intelligence, Machine Learning and Software startups, most often at Pre-Seed and Seed stage. Most of the 31 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Merantix Capital's check size?

Merantix Capital typically joins rounds of $4.3M–$6.6M at Seed, $1.1M–$3.5M at Pre-Seed and $4.5M–$19M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Merantix Capital participates in.

How do I contact Merantix Capital?

Public channels for Merantix Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Merantix Capital?

The team at Merantix Capital includes Adrian Locher (Founder, CEO and General Partner), Janette Wiget (Chief Financial Officer) and Rasmus Rothe (Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Merantix Capital Merantix Capital Find emails